New drugs and combinations for the treatment of soft-tissue sarcoma: a review

por Somaiah, Neeta, von Mehren, Margaret
Publicado 2012

Succinate Dehydrogenase Deficiency in Pediatric and Adult Gastrointestinal Stromal Tumors

por Belinsky, Martin G., Rink, Lori, von Mehren, Margaret
Publicado 2013

Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study

por Chun, Yun Shin, Huang, Min, Rink, Lori, Von Mehren, Margaret
Publicado 2014

Early and Next-Generation KIT/PDGFRA Kinase Inhibitors and the Future of Treatment for Advanced Gastrointestinal Stromal Tumor

por Bauer, Sebastian, George, Suzanne, von Mehren, Margaret, Heinrich, Michael C.
Publicado 2021

Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage

por Patel, Dhara, Handorf, Elizabeth, von Mehren, Margaret, Martin, Lainie, Movva, Sujana
Publicado 2019

Advances and Challenges on Management of Gastrointestinal Stromal Tumors

por Mei, Lin, Du, Wei, Idowu, Michael, von Mehren, Margaret, Boikos, Sosipatros A.
Publicado 2018

ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor

por Rink, Lori, Ochs, Michael F., Zhou, Yan, von Mehren, Margaret, Godwin, Andrew K.
Publicado 2013

Head and Neck Sarcomas: A Comprehensive Cancer Center Experience

por Tejani, Mohamedtaki A., Galloway, Thomas J., Lango, Miriam, Ridge, John A., von Mehren, Margaret
Publicado 2013

An unusual site of metastasis from gastrointestinal stromal tumor

por Cauchi, Carolina, Trent, Jonathan C., Edwards, Kristin, Davey, Monica, Lopez, Massimo, Yu, Jian Q., von Mehren, Margaret
Publicado 2010

Succinate dehydrogenase deficiency in a PDGFRA mutated GIST

por Belinsky, Martin G., Cai, Kathy Q., Zhou, Yan, Luo, Biao, Pei, Jianming, Rink, Lori, von Mehren, Margaret
Publicado 2017

Multi-platform profiling of over 2000 sarcomas: Identification of biomarkers and novel therapeutic targets

por Movva, Sujana, Wen, Wenhsiang, Chen, Wangjuh, Millis, Sherri Z., Gatalica, Zoran, Reddy, Sandeep, von Mehren, Margaret, Van Tine, Brian A.
Publicado 2015

Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinica...

por von Mehren, Margaret, Heinrich, Michael C., Shi, Hongliang, Iannazzo, Sergio, Mankoski, Raymond, Dimitrijević, Saša, Hoehn, Gerard, Chiroli, Silvia, George, Suzanne
Publicado 2021

Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer

por Cole, Marion, Parajuli, Shobha, Laske, Douglas, Goldstein, Lori, Morrison, Tara, Mukherjee, Abir, Tumelty, Kathryn, Tetzlaff, Eric, von Mehren, Margaret, Inniss, Susan
Publicado 2014

Somatic loss of function mutations in neurofibromin 1 and MYC associated factor X genes identified by exome-wide sequencing in a wild-type GIST case

por Belinsky, Martin G., Rink, Lori, Cai, Kathy Q., Capuzzi, Stephen J., Hoang, Yen, Chien, Jeremy, Godwin, Andrew K., von Mehren, Margaret
Publicado 2015

Differential Expression of Cysteine Dioxygenase 1 in Complex Karyotype Liposarcomas

por Shaker, Mohammed, Pascarelli, Kara M, Plantinga, Matthew J, Love, Miles A, Lazar, Alexander J, Ingram, Davis R, von Mehren, Margaret, Lev, Dina, Kipling, David, Broccoli, Dominique
Publicado 2014

Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin

por Jones, Robin L., Maki, Robert G., Patel, Shreyaskumar R., Wang, George, McGowan, Tracy A., Shalaby, Waleed S., Knoblauch, Roland E., von Mehren, Margaret, Demetri, George D.
Publicado 2019

A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors

por von Mehren, Margaret, Britten, Carolyn D., Pieslor, Peter, Saville, Wayne, Vassos, Artemios, Harris, Sarah, Galluppi, Gerald R., Darif, Mohamed, Wainberg, Zev A., Cohen, Roger B., Leong, Stephen
Publicado 2014

Phase II Study of Ponatinib in Advanced Gastrointestinal Stromal Tumors: Efficacy, Safety, and Impact of Liquid Biopsy and Other Biomarkers

por George, Suzanne, von Mehren, Margaret, Fletcher, Jonathan A., Sun, Jichao, Zhang, Sen, Pritchard, Justin R., Hodgson, John Graeme, Kerstein, David, Rivera, Victor M., Haluska, Frank G., Heinrich, Michael C.
Publicado 2022

Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor

por Kozinova, Marya, Joshi, Shalina, Ye, Shuai, Belinsky, Martin G., Sharipova, Dinara, Farma, Jeffrey M., Reddy, Sanjay S., Litwin, Samuel, Devarajan, Karthik, Campos, Alex Rosa, Yu, Yi, Schwartz, Brian, von Mehren, Margaret, Rink, Lori
Publicado 2021

Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib

por Janku, Filip, Abdul Razak, Albiruni R., Chi, Ping, Heinrich, Michael C., von Mehren, Margaret, Jones, Robin L., Ganjoo, Kristen, Trent, Jonathan, Gelderblom, Hans, Somaiah, Neeta, Hu, Simin, Rosen, Oliver, Su, Ying, Ruiz-Soto, Rodrigo, Gordon, Michael, George, Suzanne
Publicado 2020